| Control (n = 20) | T2DM patients |  |
---|---|---|---|
 |  | HbA1c < 7% (n = 55) | HbA1c ≥ 7% (n = 36) |
LV structure | |||
LVEDVI (mL/m2) | 74.71 ± 12.50 | 73.47 ± 13.91 | 69.30 ± 13.64 |
LVESVI (mL/m2) | 30.07 ± 7.01 | 30.66 ± 7.72 | 29.74 ± 6.14 |
SVI | 44.65 ± 7.82 | 42.80 ± 8.21 | 39.57 ± 8.27 |
LVMI (g/m2) | 52.30 ± 14.25 | 56.02 ± 13.72 | 61.72 ± 14.48* |
Systolic LV function | |||
LVEF (%) | 59.92 ± 5.65 | 58.44 ± 5.32 | 57.06 ± 3.29 |
LVGRS (%) | 41.41 ± 5.14 | 39.18 ± 5.58 | 38.80 ± 6.24 |
LVGCS (%) |  − 22.87 ± 4.11 |  − 19.05 ± 3.27* |  − 18.27 ± 2.14* |
LVGLS (%) |  − 22.89 ± 3.05 |  − 18.41 ± 3.04* |  − 16.72 ± 3.87*†|
Diastolic LV function | |||
LVRSR (1/s) |  − 2.31 ± 0.45 |  − 2.20 ± 0.35 |  − 2.05 ± 0.36 |
LVCSR (1/s) | 1.36 ± 0.27 | 0.99 ± 0.26* | 0.81 ± 0.24*†|
LVLSR (1/s) | 1.28 ± 0.26 | 1.10 ± 0.21* | 0.94 ± 0.20*†|
RV structure | |||
RVEDVI (mL/m2) | 82.17 ± 13.32 | 80.69 ± 28.82 | 73.06 ± 18.59 |
RVESVI (mL/m2) | 37.38 ± 7.05 | 37.47 ± 14.05 | 34.42 ± 8.86 |
SVI | 44.79 ± 7.33 | 43.22 ± 15.19 | 38.64 ± 10.07 |
RVMI (g/m2) | 10.46 ± 2.47 | 11.41 ± 2.86 | 12.64 ± 2.74* |
Systolic RV function | |||
RVEF (%) | 54.57 ± 3.12 | 53.73 ± 2.97 | 53.07 ± 2.61 |
RVGRS (%) | 40.50 ± 3.26 | 39.48 ± 3.83 | 38.36 ± 3.94 |
RVGCS (%) |  − 20.03 ± 2.79 |  − 18.72 ± 2.17 |  − 18.60 ± 3.00* |
RVGLS (%) |  − 21.46 ± 2.74 |  − 18.50 ± 2.32* |  − 17.09 ± 3.11*†|
Diastolic RV function | |||
RVRSR (1/s) |  − 2.65 ± 0.87 |  − 1.81 ± 0.45* |  − 1.44 ± 0.68* |
RVCSR (1/s) | 1.19 ± 0.18 | 0.85 ± 0.23* | 0.76 ± 0.26* |
RVLSR (1/s) | 1.14 ± 0.18 | 0.87 ± 0.13* | 0.75 ± 0.14*†|